Journal Information
Vol. 60. Issue 3.
Pages 171-172 (March 2024)
Vol. 60. Issue 3.
Pages 171-172 (March 2024)
Case Report
Full text access
Endobronchial Ultrasound-Guided Intranodal Forceps Biopsy (EBUS-IFB) in a Case of a Mediastinal Tuberculous Lymphadenitis
Visits
685
Javier Romero Lópeza,
Corresponding author
javiromlop7@gmail.com

Corresponding author.
, Gloria Toledo Muñoz-Cobob, Luis A. Padrón Frayssea
a Graduated in Medicine and Area Specialist in Pneumology at Juan Ramón Jiménez Hospital, Huelva, Spain
b Graduated in Medicine and Area Specialist in Pediatrics at Juan Ramón Jiménez Hospital, Huelva, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Full Text

A 79-year-old man with medical history of hypertension, reported fatigue and weight loss associated to discontinuous fever and night sweats over the past month. Upon admission the patient presented fever and vital signs under normal parameters (blood pressure, heart rate and oxygen saturation). There were no palpable lymph nodes, and chest examination revealed no relevant findings.

Blood test showed elevation of C-reactive protein (145mg/l). However, blood culture and infectious serology tests came back negative. Other blood parameters including complete blood count, coagulation, electrolyte tests, liver and renal function all reported normal values. Chest X-ray revealed cardiomegaly and mediastinal enlargement, with no abnormalities detected in lungs. Additional studies included: normal electrocardiogram, negative tuberculin skin test (TST), and positive interferon gamma release assays (IGRAs). For further assessment, chest and abdomen computed tomography (CT) scans with contrast were done (Fig. 1A), founding a mild free pericardial effusion with circumferential distribution, bilateral paratracheal, bilateral hiliar, and subcarinal lymph node enlargement (maximal 25mm in short axis). Lung parenchyma and bronchovascular structures were normal. Pericardiocentesis was not performed due to its low quantity, checked at transthoracic echocardiography.

Fig. 1.

(A) Chest CT-Scan: mild and free pericardial effusion, with circumferential distribution and a large subcarinal lymph node of 48mm. (B) Endobronchial ultrasound view of the opening mini-forceps in the lymph node. (C) Intranodal forceps biopsy samples. (D) Histological intranodal forceps biopsy samples: giant cell granuloma.

(0.39MB).

The evaluation was completed with a bronchoscopy, with no endoscopic remarkable findings. Bronchoalveolar lavage (BAL) for microbiological and cellular investigations was non-diagnostic. Four samples from subcarinal blinded transbronchial needle aspirations (TBNA) reported negative results in microbiological and cytopathological examinations, including Ziehl–Neelsen staining, mycobacterial cultures and mycobacterium polymerase chain reaction (PCR).

In the absence of a confirmed diagnosis, endobronchial ultrasound (EBUS) at subcarinal lymph node with TBNA and intranodal micro-forceps biopsy (IFB) using CoreDx Pulmonary Mini-Forceps, were performed (Fig. 1B, C). The EBUS-TBNA resulted in non-diagnostic findings. Histological analysis of four EBUS-IFB samples revealed local damage, highly suggestive of giant cell granuloma with necrosis corresponding to tuberculosis (Fig. 1D).

The patient was diagnosed of tuberculous lymphadenitis and probable tuberculous pericarditis. Treatment for extrapulmonary tuberculosis was initiated with the traditional regimen (2 months of HRZE and 4 months of HR).1 The patient completed treatment with a positive clinical, analytical, and radiological response (mediastinal lymphadenitis reduction and pericardiac effusion resolution), without adverse effects.

Tuberculous lymphadenitis is one of the most common presentations of extrapulmonary tuberculosis. Clinical manifestations vary depending on tuberculous lymph node locations. In its assessment, TST and IGRAs are limited since bacterial load is lower, resulting in decreased diagnostic efficacy.2 Tuberculous lymphadenitis is diagnosed by cyto-histopathological examination, PCR testing and lymph node material culture. When mediastinal lymphadenitis is present, EBUS-TBNA is a useful diagnostic tool.1,2

EBUS-TBNA shows a strong overall diagnostic yield (80%) detecting mediastinal tuberculous lymphadenitis.3 It can be used for initial diagnosis of mediastinal tuberculous lymphadenitis, although it only obtains cytologic samples and the yield of microbiological tests are limited for the lower bacterial load in lymph nodes. Detection of granulomas in cell block preparation can be challenging as well. There are emerging EBUS-guided diagnosis techniques such as IFB, which allow to take histological samples.4 It is known that the usefulness of IFB added to EBUS-TBNA improves diagnosis efficiency in mediastinal non-malignant disease (sarcoidosis and lymphoma).5 As shown in this case report, we should consider EBUS-IFB in highly suspected cases of mediastinal tuberculous lymphadenitis when other tests are not diagnostic.

Conflict of interests

The authors state that they have no conflict of interests.

References
[1]
J.F. Pascual-Pareja, R. Carrillo-Gómez, V. Hontañón-Antoñana, M. Martínez-Prieto.
Treatment of pulmonary and extrapulmonary tuberculosis.
Enferm Infecc Microbiol Clin, 36 (2018), pp. 507-516
[2]
V.D. Mathiasen, T. Lillebaek, C. Wejse.
Tuberculous lymphadenitis: a forgotten and delayed diagnosis in low-incidence countries.
Infection, 50 (2022), pp. 277-280
[3]
W. Li, T. Zhang, Y. Chen, C. Lui, W. Peng.
Diagnostic value of convex probe endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal tuberculous lymphadenitis: a systematic review and meta-analysis.
Med Sci Monit, 21 (2015), pp. 2064-2072
[4]
G. Cheng, A. Mahajan, S. Oh, S. Benzaguen, A. Chen.
Endobronchial ultrasound-guided intranodal fórceps biopsy (EBUS-IFB) – technical review.
J Thorac Dis, 11 (2019), pp. 4049-4058
[5]
A. Agrawal, U. Ghori, U. Chaddha, S. Murgu.
Combined EBUS-IFB and EBUS-TBNA alone for intrathoracic adenopathy: a meta-analysis.
Ann Thorac Surg, 114 (2022), pp. 340-348
Copyright © 2023. SEPAR
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?